Tonix Pharmaceuticals Holding Corp.
(NASDAQ : TNXP)

( )
TNXP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
-6.66%17.512.0%$159.03m
ICPTIntercept Pharmaceuticals, Inc.
-4.60%109.8518.6%$127.35m
JAZZJazz Pharmaceuticals Plc
0.42%136.602.3%$113.61m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-4.07%168.836.3%$91.29m
SAGESAGE Therapeutics, Inc.
-0.80%156.728.8%$89.75m
HZNPHorizon Pharma plc
-3.83%26.847.3%$83.66m
PRGOPerrigo Co. Plc
-2.76%47.246.8%$66.07m
ICLRICON Plc
-2.83%132.884.1%$57.01m
UTHRUnited Therapeutics Corporation
-1.78%120.8014.3%$54.81m
MNKMallinckrodt Plc
-7.23%22.0821.0%$51.42m
PTLAPortola Pharmaceuticals, Inc.
-4.94%31.977.6%$42.48m
AERIAerie Pharmaceuticals, Inc.
-4.93%46.826.9%$40.04m
ENDPEndo International Plc
-4.91%8.338.9%$36.51m
MYOKMyoKardia, Inc.
-2.71%54.312.4%$35.96m
MDCOMedicines Company
-5.14%26.5821.8%$29.62m

Company Profile

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which engages in discovering and developing pharmaceutical products to treat serious neuropsychiatric conditions and biological products to improve biodefense through potential medical counter-measures. It focuses on delivering a safe and effective long-term treatment for posttraumatic stress disorder. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.